SciClone Pharmaceuticals, Inc.$11.15 %
Analyst Rating: Hold
Stock Details
CEO
N/A
Sector
N/A
Industry
N/A
Full Time Employees
0
Address
N/A
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
Top Competitors
Income Statement
Financials
Selected Year